Clinical Trials
12 trialsNCT04861077 2026-06-02
Monitoring Breast Cancer Immunotherapy Treatment With Advanced Positron Emission Tomography Magnetic Resonance Imaging (PET/MRI)
University of Alabama at Birmingham
Phase EARLY_PHASE1 Recruiting
NCT06637306 2026-05-14
Neoadjuvant Dupilumab, Pembrolizumab, Paclitaxel, and Carboplatin in Locally Advanced Triple Negative Breast Cancer
Icahn School of Medicine at Mount Sinai
Phase EARLY_PHASE1 Recruiting
NCT02744053 2026-04-21
DCE-MRI and MBI in Assessing Tumor Response to Chemotherapy in Patients With Triple Negative Breast Cancer
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Active not recruiting
NCT06435351 2026-04-01
Personalized Dendritic Cell Vaccine Pilot for High Risk TNBC After Neoadjuvant Therapy
H. Lee Moffitt Cancer Center and Research Institute
Phase EARLY_PHASE1 Recruiting
NCT06586047 2026-03-27
Breast Cancer PSMA PET
University of Iowa
Phase EARLY_PHASE1 Recruiting
NCT06305962 2026-02-19
177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors
Radiopharm Theranostics, Ltd
Phase EARLY_PHASE1 Recruiting
NCT05333874 2026-02-09
CIPHER Study: Pilot Study to Study the Role of ctDNA in Triple Negative and HER2 Positive Early Stage
Rutgers, The State University of New Jersey
Phase EARLY_PHASE1 Active not recruiting
NCT06220214 2026-01-15
Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast Cancer
Stony Brook University
Phase EARLY_PHASE1 Recruiting
NCT06008275 2025-11-10
Neratinib in Combination With Ruxolitinib in Patients With mTNBC
Baylor Research Institute
Phase EARLY_PHASE1 Recruiting
NCT06273852 2025-08-11
A Study of the Intratumoral Microdose Administration of PBA-0405 in Patients With Solid Tumors
Pure Biologics S.A.
Phase EARLY_PHASE1 Completed
NCT06700070 2025-08-11
A Phase 0 Multicenter Study of the Pharmacodynamic Effects of Intratumoral Microdose Administration of PBA-0111 in Patients With Solid Tumors
Pure Biologics S.A.
Phase EARLY_PHASE1 Recruiting
NCT06246786 2025-07-16
Breast/Cyclosporin A/TNBC (Triple Negative Breast Cancer)
The University of Texas Health Science Center at San Antonio
Phase EARLY_PHASE1 Withdrawn